A Phase 1, Open Label, Randomized, Single Dose, Cross-Over Study To Evaluate The Effect Of Food On PF-04447943 Pharmacokinetics In Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 12 Dec 2017
At a glance
- Drugs PF 4447943 (Primary)
- Indications Cognition disorders
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Pfizer
- 12 Dec 2017 Results assessing safety and tolerability of PF-04447943 across a clinical trial program in 277 patients (Eight phase 1 studies, One phase II and One phase Ib study) presented at the 59th Annual Meeting and Exposition of the American Society of Hematology
- 03 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.